Guidance for Holmes Biopharma, Inc. (LMB)

Period Range Estimate Revenue Range Revenue Estimate Target Details
2026 N/A N/A $730.00M – 760.00M $742.50M = Maintained Details
2026 N/A N/A $730.00M – 760.00M $746.20M = Maintained Details
2025 N/A N/A $650.00M – 680.00M $627.60M = Maintained Details
2025 N/A N/A $610.00M – 630.00M $611.40M = Maintained Details
2025 N/A N/A $610.00M – 630.00M $597.30M = Maintained Details
2024 N/A N/A $520.00M – 540.00M $519.00M = Maintained Details
2024 N/A N/A $515.00M – 535.00M $515.60M = Maintained Details
2024 N/A N/A $510.00M – 530.00M $515.10M = Maintained Details
2024 N/A N/A $510.00M – 530.00M $541.10M = Maintained Details
2023 N/A N/A $490.00M – 520.00M $501.00M = Maintained Details
2023 N/A N/A $490.00M – 520.00M $495.70M = Maintained Details
2023 N/A N/A $490.00M – 520.00M $529.00M Lowered Details
2021 N/A N/A $480.00M – 510.00M $490.00M = Maintained Details
2021 N/A N/A $480.00M – 520.00M $539.65M = Maintained Details
2020 N/A N/A $560.00M – 600.00M $567.46M = Maintained Details
2020 N/A N/A $560.00M – 600.00M $536.30M = Maintained Details
2019 N/A N/A $550.00M – 570.00M $559.85M = Maintained Details
2019 N/A N/A $560.00M $559.98M = Maintained Details
2019 N/A N/A $560.00M $562.50M = Maintained Details
2018 N/A N/A $530.00M – 550.00M $541.82M = Maintained Details
2018 N/A N/A $530.00M – 550.00M $527.77M = Maintained Details
Q2 2018 N/A N/A $520.00M – 540.00M $520.67M = Maintained Details
2017 N/A N/A $460.00M – 480.00M N/A = Maintained Details
Q4 2017 N/A N/A $460.00M – 470.00M N/A = Maintained Details
Q3 2017 N/A N/A $460.00M – 480.00M $478.53M = Maintained Details